Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
about
Percutaneous patent foramen ovale closure for cryptogenic stroke: learning from clinical trial and error.Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.Patent foramen ovale and cryptogenic stroke: contemporary evidence and treatment.Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.Response by Merkler et al to Letter Regarding Article, "Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale".Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data.Highlights From the 2017 Cardiovascular and Stroke Nursing Clinical Symposium.Paradoxical emboli following a pulmonary embolus in the presence of a patent foramen ovale.Closure of patent foramen ovale in "cryptogenic" stroke: Has the story come to an end?Percutaneous closure of a patent foramen ovale after cryptogenic stroke.[Therapy changes after stroke in patients with open foramen ovale? : Patent Foramen Ovale Closure or Anticoagulants versus Antiplatelet Therapy to Prevent Stroke Recurrence Trial (CLOSE), Randomized Evaluation of Recurrent Stroke Comparing PFO ClosuCorrespondence (reply): In Reply:.Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke.PFO Closure and Stroke.Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: Meta-Analysis of Five Randomized Controlled Trials with 3440 Patients.Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.Updates on Prevention of Cardioembolic Strokes.Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.A young woman with a symptomatic patent foramen ovale: Natasha's fascinating story.Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guidelinePatent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidencePatent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trialsManagement of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief reviewPatent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke preventionPatent foramen ovale in an old patient with ischemic stroke following carotid surgeryPatent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trialsCardioembolic stroke: everything has changed
P2860
Q47148234-71657CB6-8014-4B00-A5CF-3576FA49FCD9Q47260521-450123CA-8320-4E3C-BB12-33786000755AQ47562490-D1F63030-F208-419D-BBCF-1774A52E35DAQ47660182-04DDCD9A-E7F5-41C1-8C2C-AA8CE31D7BC0Q47945959-605D260F-3128-495E-BEB4-C4800713092CQ48247951-6C973715-335A-425B-8D29-BF00D0610A22Q49233860-DF30DA0B-B3F6-4A61-A1FC-C823B02D62FAQ49293334-E9A49BFA-213A-4CD2-A2C2-7A617C24374FQ49330256-3F465B17-2503-43B3-8F29-94EEAA82B22EQ49591116-FD20A4DE-7FCF-4FA1-A355-84F1E2C3B2DEQ50098455-31F4A341-7DD5-43EA-BC2A-675D07AADAD2Q50143498-A3CA0EA1-B5C9-4F86-B4C7-ABA91AA1630CQ50146736-583A1303-ACFE-48CE-9A27-6CF163953DABQ50333463-AC58434F-2EE9-4AB0-A5DE-44B91E88204AQ51733405-82B303E0-5C98-4F9B-91C5-7FC42767F19AQ53832627-79030309-A56F-46F8-8746-BCC99DF8309EQ55352254-2C082711-0A25-4115-AC4D-4DE69A0676B7Q55359342-862F411E-9BAC-4B8B-B9F1-D52A43443304Q55363978-F2813D0B-A82F-4D8C-A05B-EFCAB1261200Q55395691-5942BBC7-F79B-433A-85E1-EADE8589FB95Q55505555-B42F8674-1493-4C60-A871-7BEF12796CA2Q56566721-E529E341-87BC-4CD2-A789-D801211D8048Q56804853-C0B8B81C-6D80-4B70-B6B1-2835D0458368Q57150942-280B381C-AA9B-41A0-A955-78590005C793Q57652818-C09F274E-21BF-4211-95ED-5D70D2D0D4C9Q57652832-9DF63C40-5D2D-4DE0-835C-E556EE55B81AQ57824558-16E3C410-2CD3-4076-9D09-2A90428AF336Q58564236-517F047F-8E60-4999-AD0F-0CBD0A00429BQ58706609-BA64C5FE-2089-46D7-9BB4-BC762534F3BFQ58769055-33E7A439-7C1C-4DD4-B72C-D9A1C8968FD6
P2860
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@en
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@nl
type
label
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@en
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@nl
prefLabel
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@en
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@nl
P2093
P356
P1476
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
@en
P2093
Christina Sjöstrand
David Hildick-Smith
Gore REDUCE Clinical Study Investigators
J David Spence
Jens E Nielsen-Kudsk
John F Rhodes
Lars Søndergaard
Lars Thomassen
Magnus Settergren
Risto O Roine
P304
P356
10.1056/NEJMOA1707404
P407
P577
2017-09-01T00:00:00Z